Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ARE logo ARE
Upturn stock ratingUpturn stock rating
ARE logo

Alexandria Real Estate Equities Inc (ARE)

Upturn stock ratingUpturn stock rating
$85.57
Last Close (24-hour delay)
Profit since last BUY4.71%
upturn advisory
Consider higher Upturn Star rating
BUY since 13 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

09/15/2025: ARE (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

13 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $96.42

1 Year Target Price $96.42

Analysts Price Target For last 52 week
$96.42 Target price
52w Low $66.16
Current$85.57
52w High $118.71

Analysis of Past Performance

Type Stock
Historic Profit -24.95%
Avg. Invested days 20
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/15/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 14.50B USD
Price to earnings Ratio -
1Y Target Price 96.42
Price to earnings Ratio -
1Y Target Price 96.42
Volume (30-day avg) 13
Beta 1.31
52 Weeks Range 66.16 - 118.71
Updated Date 09/15/2025
52 Weeks Range 66.16 - 118.71
Updated Date 09/15/2025
Dividends yield (FY) 6.21%
Basic EPS (TTM) -0.13

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -0.33%
Operating Margin (TTM) 20.36%

Management Effectiveness

Return on Assets (TTM) 1.2%
Return on Equity (TTM) 0.78%

Valuation

Trailing PE -
Forward PE 16.69
Enterprise Value 27634604971
Price to Sales(TTM) 4.68
Enterprise Value 27634604971
Price to Sales(TTM) 4.68
Enterprise Value to Revenue 9.15
Enterprise Value to EBITDA 16.34
Shares Outstanding 170720992
Shares Floating 154047617
Shares Outstanding 170720992
Shares Floating 154047617
Percent Insiders 0.99
Percent Institutions 95.73

ai summary icon Upturn AI SWOT

Alexandria Real Estate Equities Inc

stock logo

Company Overview

overview logo History and Background

Alexandria Real Estate Equities, Inc. (ARE) was founded in 1994. It focuses on developing and operating properties for the life science, technology, and agtech industries. It was one of the first REITs to specialize in this niche.

business area logo Core Business Areas

  • Leasing: Leasing lab space and office buildings to life science, technology, and agtech companies.
  • Development and Redevelopment: Developing new properties and redeveloping existing ones to meet the specific needs of tenants.
  • Property Management: Managing properties, including maintenance, security, and tenant services.

leadership logo Leadership and Structure

The company is led by Joel S. Marcus (Executive Chairman and Founder). Marc Bazin is the Chief Executive Officer. The organizational structure includes departments for development, leasing, finance, and property management.

Top Products and Market Share

overview logo Key Offerings

  • Lab Space: Specialized laboratory facilities for pharmaceutical, biotechnology, and other life science companies. ARE is a leading provider of such space, but definitive market share data is difficult to ascertain. Competitors include Boston Properties (BXP) and Healthpeak Properties (PEAK).
  • Office Buildings: Office space tailored to the needs of technology and agtech companies. Market share information is difficult to ascertain. Competitors include SL Green Realty Corp (SLG) and Vornado Realty Trust (VNO).

Market Dynamics

industry overview logo Industry Overview

The life science, technology, and agtech industries are experiencing growth, driving demand for specialized real estate. This growth is due to increased funding, research and development activities, and technological advancements.

Positioning

Alexandria Real Estate Equities, Inc. is a leading REIT in the life science, technology, and agtech real estate niche. Its competitive advantage lies in its expertise in developing and managing properties for these industries.

Total Addressable Market (TAM)

The TAM for life science real estate is estimated to be in the tens of billions of dollars. Alexandria is well positioned to capture a significant portion of this TAM due to its established presence and specialized expertise.

Upturn SWOT Analysis

Strengths

  • Specialized Expertise
  • High-Quality Portfolio
  • Strong Tenant Relationships
  • Geographically Concentrated Portfolio

Weaknesses

  • Concentration in Specific Industries
  • High Development Costs
  • Exposure to Economic Downturns
  • High debt load

Opportunities

  • Growing Demand for Lab Space
  • Expansion into New Markets
  • Increasing Research and Development Funding
  • Develop new properties with advanced technologies

Threats

  • Economic Recession
  • Increased Competition
  • Changes in Government Regulations
  • Rising Interest Rates

Competitors and Market Share

competitor logo Key Competitors

  • BXP
  • PEAK
  • SLG
  • VNO

Competitive Landscape

Alexandria Real Estate Equities, Inc. has a competitive advantage due to its specialized expertise and high-quality portfolio. However, it faces competition from other REITs and developers. Some competitors have broader investment mandates that allow them flexibility.

Major Acquisitions

BioMed Realty Trust

  • Year: 2016
  • Acquisition Price (USD millions): 8000
  • Strategic Rationale: Expanded ARE's portfolio and strengthened its position in key life science markets.

Growth Trajectory and Initiatives

Historical Growth: Alexandria Real Estate Equities, Inc. has experienced significant growth in recent years due to the increasing demand for lab space and office buildings in the life science, technology, and agtech industries.

Future Projections: Future growth projections require access to analyst estimates, available from financial data providers.

Recent Initiatives: Recent initiatives require access to company announcements and news releases, available from ARE's investor relations website.

Summary

Alexandria Real Estate Equities, Inc. is a strong company due to its specialized focus and high-quality properties. Its focus on the life science, technology, and agtech industries allows it to command premium rents. It should be cautious about economic downturns and rising interest rates due to the nature of Real Estate.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company reports
  • Analyst reports
  • Industry publications

Disclaimers:

This analysis is for informational purposes only and does not constitute financial advice. Market share data is approximate and may vary. Financial data needs to be verified with updated quarterly reports.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Alexandria Real Estate Equities Inc

Exchange NYSE
Headquaters Pasadena, CA, United States
IPO Launch date 1997-05-27
CEO & Chief Investment Officer Mr. Peter M. Moglia
Sector Real Estate
Industry REIT - Office
Full time employees 552
Full time employees 552

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of June 30, 2025, Alexandria has a total market capitalization of $25.7 billion and an asset base in North America that includes 39.7 million RSF of operating properties and 4.4 million RSF of Class A/A+ properties undergoing construction and one 100% pre-leased committed near-term project expected to commence construction in the next year. Alexandria has a long-standing and proven track record of developing Class A/A+ properties clustered in highly dynamic and collaborative Megacampus environments that enhance our tenants' ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.